Abstract
Purpose
The world’s older population is growing rapidly and the need to find measures to combat age-associated decline of physical, mental, and cognitive functions and improve their health-related quality of life (HRQOL) is escalating. Biobran/MGN-3, an arabinoxylan rice bran, has been previously reported to improve the quality of life in cancer patients. The objective of the current study was to examine the effect of a low dose of Biobran/MGN-3 supplementation on the HRQOL in a healthy older adult population.
Methods
Sixty apparently healthy subjects, 40 males and 20 females, over 56 years old were recruited and blindly randomized into two group receiving either placebo or Biobran/MGN-3 (250 mg/day for 3 months). Participants did not take any vitamins or medications during the study and their health was closely monitored. HRQOL was assessed at the initiation and termination of the study using the previously validated Arabic version of SF-12v2 questionnaire.
Results
For all measured HRQOL domains, there was no statistically significant difference in baseline scores between the two groups. Compared to baseline values and placebo-treated subjects, Biobran/MGN-3 supplementation significantly enhanced the levels of physical and mental component summary scores as well as role-physical, bodily pain, vitality, and social functioning subdomain scores.
Conclusion
These results show that Biobran/MGN-3 is a promising psychoneuroimmune modulatory agent that could improve the HRQOL in healthy old adults.
Similar content being viewed by others
Abbreviations
- HRQOL:
-
Health-related Quality of Life
- PCS:
-
Physical Component Summary
- MCS:
-
Mental Component Summary
- PF:
-
Physical Functioning
- RP:
-
Role-Physical
- RE:
-
Role Emotion
- BP:
-
Bodily Pain
- MH:
-
Mental Health
- VT:
-
Vitality
- SF:
-
Social Functioning
- WHO:
-
World Health Organization
- QOL:
-
Quality of Life
- GH:
-
General Health
- PA:
-
Physical Activity
References
He, W., Goodkind, D., & Kowal, P. (2016). An aging world: 2015. Washington, DC: U.S. Census Bureau, International Population Reports, U.S. Government Publishing Office.
United Nations, Department of Economic and Social Affairs, Population Division. (2017). World population aging 2017- highlights. (ST/ESA/SER.A/397).
World Health Organization. (2002). “Proposed working definition of an older person in Africa for the MDS Project.” Retrieved July 11, 2019, from http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html.
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., et al. (2014). Geroscience: Linking aging to chronic disease. Cell,159, 709–713.
WHO. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no 2, p. 100) and entered into force on 7 April 1948.
Kuyken, W., & Group, T.W. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine,41, 1403–1409.
Hays, R. D., & Reeve, B. B. (2010). Measurement and modeling of health-related quality of life. In J. Killewo, H. K. Heggenhougen, & S. R. Quah (Eds.), Epidemiology and demography in public health (pp. 195–205). San Diego: Academic Press.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association,273, 59–65.
Carr, A. J., & Higginson, I. J. (2001). Are quality of life measures patient centered? British Medical Journal,322, 1357.
Ware, J. E., Kosinski, M., Turner Bowker, D. M., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln: Quality Metrics.
Cheak-Zamora, N. C., Wyrwich, K. W., & McBride, T. D. (2009). Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Quality of Life Research,18, 727–735.
Islam, N., Khan, I. H., Ferdous, N., & Rasker, J. J. (2017). Translation, cultural adaptation and validation of the English “Short form SF 12v2” into Bengali in rheumatoid arthritis patients. Health and Quality of Life Outcomes,15, 109.
Montazeri, A., Vahdaninia, M., Mousavi, S. J., Asadi-Lari, M., Omidvari, S., & Tavousi, M. (2011). The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): A population-based validation study from Tehran, Iran. Health and Quality of Life Outcomes,9, 12.
Monteagudo Piqueras, O., Hernando Arizaleta, L., & Palomar Rodriguez, J. A. (2009). Reference values of the Spanish version of the SF-12v2 for the diabetic population. Gaceta Sanitaria,23, 526–532.
Kim, S. H., Jo, M. W., Ahn, J., Ock, M., Shin, S., & Park, J. (2014). Assessment of psychometric properties of the Korean SF-12 v2 in the general population. BMC Public Health,14, 1086.
Obtel, M., El Rhazi, K., Elhold, S., Benjelloune, M., Gnatiuc, L., & Nejjari, C. (2013). Crosscultural adaptation of the 12-Item Short-Form survey instrument in a Moroccan representative Survey. Southern African Journal of Epidemiology and Infection,28, 166–171.
Fleishman, J. A., Selim, A. J., & Kazis, L. E. (2010). Deriving SF-12v2 physical and mental health summary scores: A comparison of different scoring algorithms. Quality of Life Research,19, 231–241.
Taft, C. (2001). Reply to Drs Ware and Kosinski. Quality of Life Research,10, 415–420.
Zachariae, R. (2009). Psychoneuroimmunology: A bio-psycho-social approach to health and disease. Scandinavian Journal of Psychology,50(6), 645–651.
Antoni, H. M. (2003). Psychoneuroendocrinology and psychoneuroimmunology of cancer: Plausible mechanisms worth pursuing? Brain, Behavior, and Immunity,17(Suppl 1), S84–S91.
Green McDonald, P., O’Connell, M., & Lutgendorf, S. K. (2013). Psychoneuroimmunology and cancer: A decade of discovery, paradigm shifts, and methodological innovations. Brain, Behavior, and Immunity,30(Suppl), S1–S9.
Vitlic, A., Lord, J. M., & Philips, A. C. (2014). Stress, ageing and their influence on functional, cellular and molecular aspects of the immune system. Age.,36, 1169–1185.
Morey, J. N., Boggero, I. A., Scott, A. B., & Segerstrom, S. C. (2015). Current directions in stress and human immune function. Current Opinion in Psychology.,5, 13–17.
Sartori, A. C., Vance, D. E., Slater, L. Z., & Crowe, M. (2012). The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. Journal of Neuroscience Nursing,44, 206–217.
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016). Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology (Berl),233, 1623–1636.
Li, C. T., Chen, M. H., Lin, W. C., Hong, C. J., Yang, B. H., Liu, R. S., et al. (2016). The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study. Human Brain Mapping,37, 1080–1090.
Noaman, E., Badr El-Din, N. K., Bibars, M. A., Abou Mossallam, A. A., & Ghoneum, M. (2008). Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Letters,268, 348–359.
Badr El-Din, N. K., Noaman, E., & Ghoneum, M. (2008). In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutrition and Cancer,60, 235–244.
Takahara, K., & Sano, K. (2004). The life prolongation and QOL improvement effect of rice bran arabinoxylan derivative (MGN-3. Bio-Bran) for progressive cancer. Clinical Pharmacology and Therapeutics,14, 267–271.
Hajto, T., Horvath, A., & Papp, S. (2016). Improvement of quality of life in tumor patients after an immunomodulatory treatment with standardized mistletoe lectin and arabinoxylan plant extracts. International Journal of Neurorehabilitation,3, 1–3.
Kawai, T. (2004). A case of a patient with umbilical metstasis of recurrent cancer (Sister Mary Joseph’s Nodule, SMJN) who has survived for a long time under immunomodulatory supplement therapy. Clinical Pharmacology and Therapeutics,14, 281–288.
Ghoneum, M. (1998). Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochemical and Biophysical Research Communications,243, 25–29.
Ware, J. E., Keller, S. D., Gandek, B., Brazier, J. E., & Sullivan, M. (1995). Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment. International Journal of Technology Assessment in Health Care.,11, 525–551.
Elsaid, A. F., Shaheen, M., & Ghoneum, M. (2018). Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial. Experimental and Therapeutic Medicine,15, 2313–2320.
Bang, M. H., Van Riep, T., Thinh, N. T., le Song, H., Dung, T. T., Van Truong, L., et al. (2010). Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: A three-year randomized clinical trial. Anticancer Research,30, 5145–5151.
Warburton, D. E., Nicol, C. W., & Bredin, S. S. (2006). Health benefits of physical activity: The evidence. Canadian Medical Association Journal,174, 801–809.
Hong, S. Y., Hughes, S., & Prohaska, T. (2008). Factors affecting exercise attendance and completion in sedentary older adults: A meta-analytic approach. Journal of Physical Activity and Health,5, 385–397.
Hupin, D., Roche, F., Gremeaux, V., Chatard, J. C., Oriol, M., Gaspoz, J. M., et al. (2015). Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥ 60 years: A systematic review and meta-analysis. British Journal of Sports Medicine,49(19), 1262–1267.
Kohl, H. W., Craig, C. L., Lambert, E. V., Inoue, S., Alkandari, J. R., Leetongin, G., et al. (2012). The pandemic of physical inactivity: Global action for public health. Lancet,380, 294–305.
Carlson, S. A., Fulton, J. E., Schoenborn, C. A., & Loustalot, F. (2010). Trend and prevalence estimates based on the 2008 Physical Activity Guidelines for Americans. American Journal of Preventive Medicine,39, 305–313.
Kruger, J., Carlson, S. A., & Buchner, D. (2007). How active are older Americans? Preventing Chronic Disease,4, A53.
World Health Organization. (2010). Global recommendations on physical activity for health. Geneva: World Health Organization.
Sun, F., Norman, I. J., & While, A. E. (2013). Physical activity in older people: A systematic review. BMC Public Health,13, 449.
Luthy, C., Cedraschi, C., Allaz, A. F., Herrmann, F. R., & Ludwig, C. (2015). Health status and quality of life: Results from a national survey in a community-dwelling sample of elderly people. Quality of Life Research,24, 1687–1696.
Cedraschi, C., Luthy, C., Allaz, A. F., Herrmann, F. R., & Ludwig, C. (2016). Low back pain and health-related quality of life in community-dwelling older adults. European Spine Journal,25, 2822–2832.
Hicks, G. E., Gaines, J. M., Shardell, M., & Simonsick, E. M. (2008). Associations of back and leg pain with health status and functional capacity of older adults: Findings from the retirement community back pain study. Arthritis & Rheumatology,59, 1306–1313.
Morelli, S. A., Lieberman, M. D., & Zaki, J. (2015). The emerging study of positive empathy. Social and Personality Psychology Compass,9, 57–68.
Gow, A. J., Corley, J., Starr, J. M., & Deary, I. J. (2013). Which social network or support factors are associated with cognitive abilities in old age? Gerontology,59, 454–463.
O’Luanaigh, C., O’Connell, H., Chin, A. V., Hamilton, F., Coen, R., Walsh, C., et al. (2012). Loneliness and cognition in older people: the Dublin Healthy Ageing study. Aging & Mental Health,16, 347–352.
Cole, S. W., Hawkley, L. C., Arevalo, J. M. G., & Cacioppo, J. T. (2011). Transcript origin analysis identifies antigen presenting cells as primary targets of socially regulated leukocyte gene expression. Proceedings of the National academy of Sciences of the United States of America,15, 3080–3085.
Creswell, J. D., Irwin, M. R., Burklund, L. J., Lieberman, M. D., Arevalo, J. M. G., Ma, J., et al. (2012). Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: A small randomized controlled trial. Brain, Behavior, and Immunity,26, 1095–1101.
Berra, K. (2003). The effect of lifestyle interventions on quality of life and patient satisfaction with health and health care. Journal of Cardiovascular Nursing,18, 319–325.
Borg, C., Hallberg, I. R., & Blomqvist, K. (2006). Life satisfaction among older people (65+) with reduced self-care capacity: The relationship to social, health and financial aspects. Journal of Clinical Nursing,15, 607–618.
Ader, R., Cohen, N., & Felten, D. (1995). Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet,345, 99–103.
Tracey, K. J. (2009). Reflex control of immunity. Nature Reviews Immunology,9, 418–428.
Pavlov, V. A., & Tracey, K. J. (2015). Neural circuitry and immunity. Immunologic Research,63, 38–57.
Schiepers, O. J., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry,29, 201–217.
Lotrich, F. E. (2015). Inflammatory cytokine-associated depression. Brain Research,1617, 113–125.
Zhang, X., Du, Q., Liu, C., Yang, Y., Wang, J., Duan, S., et al. (2016). Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats. International Immunopharmacology,36, 300–304.
Pacheco, R., Prado, C. E., Barrientos, M. J., & Bernales, S. (2009). Role of dopamine in the physiology of T-cells and dendritic cells. Journal of Neuroimmunology,216, 8–19.
Rosas-Ballina, M., Olofsson, P. S., Ochani, M., Valdés-Ferrer, S. I., Levine, Y. A., Reardon, C., et al. (2011). Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science,334, 98–101.
Duggal, N. A., Upton, J., Phillips, A. C., Hampson, P., & Lord, J. M. (2015). NK cell immunesenescence is increased by psychological but not physical stress in older adults associated with raised cortisol and reduced perforin expression. Age (Dordrecht, Netherlands),37, 9748.
Irwin, M., Patterson, T., Smith, T. L., Caldwell, C., Brown, S. A., Gillin, J. C., et al. (1990). Reduction of immune function in life stress and depression. Biological Psychiatry,27, 22–30.
Maydych, V., Claus, M., Dychus, N., Ebel, M., Damaschke, J., Diestel, S., et al. (2017). Impact of chronic and acute academic stress on lymphocyte subsets and monocyte function. PLoS ONE,12, e0188108.
Glaser, R., Rice, J., Speicher, C. E., Stout, J. C., & Kiecolt-Glaser, J. K. (1986). Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behavioral Neuroscience,100, 675–678.
Kiecolt-Glaser, J. K., Garner, W., Speicher, C., Penn, G. M., Holliday, J., & Glaser, R. (1984). Psychosocial modifiers of immunocompetence in medical students. Psychosomatic Medicine,46, 7–14.
Glaser, R., Kiecolt-Glaser, J. K., Stout, J. C., Tarr, K. L., Speicher, C. E., & Holliday, J. E. (1985). Stress-related impairments in cellular immunity. Psychiatry Research,16, 233–239.
Frick, L. R., Arcos, M. L., Rapanelli, M., Zappia, M. P., Brocco, M., Mongini, C., et al. (2009). Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice. Stress,12, 134–143.
Kiecolt-Glaser, J. K., Glaser, R., Shuttleworth, E. C., Dyer, C. S., Ogrocki, P., & Speicher, C. E. (1987). Chronic stress and immunity in family caregivers of Alzheimer’s disease victims. Psychosomatic Medicine,49, 523–535.
Ghoneum, M. (1998). Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MGN-3). International Journal of Immunotherapy,14, 89–99.
Ghoneum, M., & Agrawal, S. (2011). Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). International Journal of Immunopathology and Pharmacology,24, 941–948.
Ghoneum, M., & Agrawal, S. (2014). MGN-3/Biobran enhances generation of cytotoxic CD8 + T cells via upregulation of dec-205 expression on dendritic cells. International Journal of Immunopathology and Pharmacology,27, 523–530.
Chiossone, L., Dumas, P. Y., Vienne, M., & Vivier, E. (2018). Natural killer cells and other innate lymphoid cells in cancer. Nature Reviews Immunology,18, 671–688.
Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F., & Berneman, Z. N. (2014). Clinical use of dendritic cells for cancer therapy. Lancet Oncology,15, e257–e267.
Chrisikos, T. T., Zhou, Y., Slone, N., Babcock, R., Watowich, S. S., & Li, H. S. (2018). Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer. Molecular Immunology,110, 24–39.
Lorusso, L., Mikhaylova, S. V., Capelli, E., Ferrari, D., Ngonga, G. K., & Ricevuti, G. (2009). Immunological aspects of chronic fatigue syndrome. Autoimmunity Reviews,8, 287–291.
Acknowledgements
The authors would like to thank Daiwa Pharmaceutical Co., Ltd., Tokyo, Japan for providing Biobran/MGN-3. We also appreciate the assistance of Dr. B. J. Winjum in preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Elsaid, Dr. Fahmi, and Dr. Shaheen have nothing to disclose; Dr. Ghoneum has received grants from Daiwa Pharmaceutical Co., Ltd., Japan, outside the submitted work.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Zagazig University Hospital, Faculty of Medicine, IRB approval no. 1507, June 2018) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Elsaid, A.F., Fahmi, R.M., Shaheen, M. et al. The enhancing effects of Biobran/MGN-3, an arabinoxylan rice bran, on healthy old adults’ health-related quality of life: a randomized, double-blind, placebo-controlled clinical trial. Qual Life Res 29, 357–367 (2020). https://doi.org/10.1007/s11136-019-02286-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-019-02286-7